Scientific Advisory Board
Lorenz Studer, MD
Lorenz Studer, MD, is the founder and director of the Center for Stem Cell Biology at Memorial-Sloan Kettering in New York. He is also a scientific co-founder of BlueRock Therapeutics. Dr. Studer was named a recipient of the MacArthur Fellowship for his work on stem cell-derived treatments for Parkinson’s disease. He received his MD from the University of Bern, Switzerland.
Sally Temple, PhD
Sally Temple, PhD, is the co-founder and scientific director of the Neural Stem Cell Institute and a professor of neuroscience and neuropharmacology at Albany Medical College. Dr. Temple is the principal investigator in her lab focused on studying neural stem cells and using this knowledge to develop therapies for central nervous system (CNS) disorders. She received her PhD from the University College London and competed her postdoctoral fellowship at Columbia University.
Mahendra Rao, MD, PhD
Mahendra Rao, MD, PhD, is a scientific co-founder of Q Therapeutics. Dr. Rao is internationally known for his research involving human embryonic stem cells (hESCs) and other somatic stem cells. He has worked in the stem cell field for more than 20 years with stints in academia, government and regulatory affairs, and industry. Dr. Rao received his MD (MBBS) from Bombay University in India and his PhD in developmental neurobiology from the California Institute of Technology.
Stephen Chang, PhD
Stephen Chang, PhD, has served as an executive or director for several biotechnology companies including Histogen, Stemgent, MultiCell Technologies. Dr. Chang was formerly a senior vice president of strategic initiatives and research for the New York Stem Cell Foundation. He Chang received his PhD in biological chemistry, molecular biology, and biochemistry from the University of California, Irvine.
Clifford Bechtold, MS
Clifford Bechtold, MS, is currently the chief operating officer of Biohaven, Ltd. Mr. Bechtold has more than 27 years of experience in the pharmaceutical industry, including leading neuromuscular and neurodegenerative programs at Bristol Myers Squibb. He earned his MS degree in medical microbiology from Creighton University School of Medicine and a BS from South Dakota State University.
Deok-Ho Kim, PhD
Deok-Ho Kim, PhD, is an associate professor at Johns Hopkins University Department of Biomedical Engineering. Dr. Kim's current work focuses on the development of human induced pluripotent stem cells (iPSC) based microphysiological systems for disease modeling, drug screening, and precision medicine. He received his PhD in biomedical engineering from Johns Hopkins University.
Kapil Bharti, PhD
Kapil Bharti, PhD, is a senior investigator in the NEI Ocular and Stem Cell Translational Research Section. His current work includes leading the first clinical trial in the US utilizing induced pluripotent stem cells (iPSCs) in a treatment for age-related macular degeneration. Dr. Bharti graduated with highest honors from the Panjab University in Chandigarh, India. He also holds a master's degree in biotechnology from the Maharaja Sayajirao University of Baroda in India, and a diploma in molecular cell biology at the Johann Wolfgang Goethe University at Frankfurt in Germany. Dr. Bharti obtained his PhD from Johann Wolfgang Goethe University, graduating summa cum laude.
David Sassoon, PhD
David Sassoon, PhD, is a research team director at Paris Sorbonne. His long-standing interest has been in developmental and stem cell biology in a number of tissues including skeletal muscle, skin, central nervous system (CNS) and heart. A major focus of Dr. Sassoon's research is on adult progenitor/stem cell biology and how these cells respond to stress. He received his PhD from Columbia University in the biological sciences and performed his postdoctoral studies at the Pasteur Institute in Paris, France, before directing his research group at Boston University Medical School.